]>
IRCT20170227032797N2 IRCT 2018-03-05 Mashhad University of Medical Sciences Effect of Dorema ammoniacum and acupuncture in treatment of cerebral stroke The effect of Dorema ammoniacum and acupuncture on the clinical improvement of patients with cerebral stroke 2017-07-06 anticipated 57 Complete https://irct.ir/trial/25469 interventional Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Patients are randomly assigned into three categories: A, B, and C using Random number table. N/A Cerebral infarction. Intervention 1: Intervention group: In the first intervention group, standardized treatment and physiotherapy, and also Dorema ammoniacum gum with a daily dose of one gram is given as an oral capsule, twice a day for one month. Intervention 2: Intervention group: The second intervention group receives the standard treatment and physiotherapy and also acupuncture treatment provided by an acupuncturist. The number of acupuncture sessions is twelve 30 minute sessions, three times a week. Intervention 3: Control group: In the control group, standard treatment and physiotherapy are received. Undecided - It is not yet known if there will be a plan to make this available
public Mahsa Mehrpour
Faculty of Traditional Medicine and Supplement, Mashhad University of Medical Sciences, Ferdowsi University, Azadi Square
Mashhad Iran (Islamic Republic of) 00985138848931 +98 51 3884 8931 mehrpourm911@mums.ac.ir Mashhad University of Medical Sciences scientific Dr. Hamid Reza Bahrami Taghanaki
Faculty of Traditional Medicine and Supplement, Mashhad University of Medical Sciences, Ferdowsi University, Azadi Square
Mashhad Iran (Islamic Republic of) 917794-8564 +98 51 3884 8931 bahramihr@mums.ac.ir Mashhad University of Medical Sciences Iran (Islamic Republic of) Patients with focal neurological findings that have been clinically and with brain imaging have been diagnosed with ischemic stroke Ischemia is in the superior branch of middle cerebral artery Stroke attack in less than thirty days Age between 50 and 75 years First stroke attack Modified NIHSS between 4 and 20 Patient with consciousness and stable disease condition 50 years 75 years Both Cerebral stroke of hemorrhagic type Patients suffering from systemic chronic diseases such as: uncontrolled diabetes, severe liver, cardiac, renal or pulmonary disorders or cancer Patients taking coagulants (heparin or warfarin) Patients with BMI above 35 Patients with history of acupuncture in less than a month Patients with a history of allergy to Dorema Ammoniacum Patient suffering from severe musculoskeletal or neurologic diseases before ischemic stroke Patients diagnosed with tumor or skin infections I63 Cerebral infarction Treatment - Drugs Treatment - Drugs Treatment - Drugs Intervention group: In the first intervention group, standardized treatment and physiotherapy, and also Dorema ammoniacum gum with a daily dose of one gram is given as an oral capsule, twice a day for one month. Intervention group: The second intervention group receives the standard treatment and physiotherapy and also acupuncture treatment provided by an acupuncturist. The number of acupuncture sessions is twelve 30 minute sessions, three times a week. Control group: In the control group, standard treatment and physiotherapy are received. Disability due to cerebral stroke. Timepoint: Before the intervention, After the end of the intervention. Method of measurement: MNIHSS and mRankin scales. Aspartate aminotransferase. Timepoint: before intervention and after the end of intervention. Method of measurement: blood test. Low density lipoprotein. Timepoint: before intervention and after the end of intervention. Method of measurement: blood test. High density lipoprotein. Timepoint: before intervention and after the end of intervention. Method of measurement: blood test. Alanine aminotransferase. Timepoint: before intervention and after the end of intervention. Method of measurement: blood test. Blood urea nitrogen. Timepoint: before intervention and after the end of intervention. Method of measurement: blood test. Glycosylated hemoglobin. Timepoint: before intervention and after the end of intervention. Method of measurement: blood test. Triglyceride. Timepoint: before intervention and after the end of intervention. Method of measurement: blood test. Complete Blood Count. Timepoint: before intervention and after the end of intervention. Method of measurement: blood test. Fasting blood sugar. Timepoint: before intervention and after the end of intervention. Method of measurement: blood test. Creatinine. Timepoint: before intervention and after the end of intervention. Method of measurement: blood test. Partial thromboplastin time. Timepoint: before intervention and after the end of intervention. Method of measurement: blood test. Prothrombin Time. Timepoint: before intervention and after the end of intervention. Method of measurement: blood test. International Normalized Ratio (INR). Timepoint: before intervention and after the end of intervention. Method of measurement: blood test. Cholesterol. Timepoint: before intervention and after the end of intervention. Method of measurement: blood test. Mashhad University of Medical Sciences Approved 2016-12-07 Ethics committee of Mashhad University of Medical Sciences Ethics committee of Mashhad University of Medical Sciences, Quraishi Building, Daneshgah St. Mashhad Razavi Khorasan Iran (Islamic Republic of)